The impact of your commitment towards cancer research is essential
My research focuses on breast cancer recurrence, a major hurdle in the current treatment to improve long-term patient outcome. With internal fundings, I am able to conduct more extensive experiments that allow me to gain a better understanding of what causes cancer to come back and to find therapeutic targets within recurrent tumors.
Yu Gu
PhD Candidate
Great discoveries
start with you
Our successes are rooted in our community. This commitment inspires our researchers and trainees to take on the toughest challenges and deploy bold initiatives to outsmart cancer.
The legacy
we created
with your help
Success stories
2025 Research Highlights: Where Discovery Is Headed
In 2025, researchers at the Rosalind and Morris Goodman Cancer Institute advanced discoveries tackling therapy resistance, metastasis, immunotherapy response, and rare cancers—translating fundamental molecular insight into new therapeutic directions.
Read more 
A Year in Review: Extending our impact: outreach, engagement, and trainee leadership
In 2025, GCI trainees played a leading role in shaping outreach, inclusion, and community engagement—from Research Day and Science-meets-Art to major fundraising and public-facing initiatives. Together, these efforts extend the impact of cancer research far beyond the lab.
Read more 
A Year in Review: Sixty years of discovery—and the next generation of scientific excellence at the GCI
From the discovery of the world’s first cancer biomarker to the recruitment of rising research leaders, the GCI marks 60 years of scientific excellence—while investing in the discoveries and people shaping the future of cancer care.
Read more 
Rosalind & Morris Goodman Cancer Institute all rights reserved • Privacy policy • Accessibility
Website by Riposte
